medline.ch Onkologie Gynäkologische Tumoren

	Multi-omics fusion with machine learning enables robust prediction of treatment response in ovarian cancer for precision population health. NPJ Digit Med Chen J, Mao T, Yang Y, Wu Y, Wang M, Huang X, Su L, Wei X, Xia G, Xia H, Lin S, Zhang M. PMID: 42443519 [PubMed - as supplied by publisher]
	Evaluation of a deep transfer learning-based ultrasound model for predicting HER2-positive breast cancer. Sci Rep Zhang XR, Hu JJ, Yuan SS, Chen QQ, Yu XQ, Wu Y, Wang Y, Fu XH, Shen Y. PMID: 42443352 [PubMed - as supplied by publisher]
	Navigating the cGAS-STING signaling pathway in breast cancer: Reinterpreting the paradox of antitumor and pro-metastatic. Crit Rev Oncol Hematol Xiao YX, Gao JJ, Zhang ZX, Shen XL, Wu W, Jia CC, Zhou MS, Jia H. PMID: 42442517 [PubMed - as supplied by publisher]
	Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet Oncol Turner NC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, Kalinsky K, Iwata H, Chia S, Brufsky AM, Fasching PA, Nowecki Z, Pascual J, Karadurmus N, Gal-Yam E, Chung WP, Im SA, Zambelli A, Dalenc F, Oliveira M, Ishiguro H, Huang CS, Klinowska T, Fox S, Morrow C, Robert L, Huang-Bartlett C, Bidard FC. PMID: 42442380 [PubMed - as supplied by publisher]
	Habitat-Based MRI Radiomics for Predicting Breast-Conserving Surgery Feasibility After Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study. Clin Breast Cancer Liu J, Tang M, Jia F, Wang Z, Shao Z, Ge X, Liu G, Wang J, Jiang J, Yan J, Zhao X, Zhang N, Ren W, Xu X, Xiong Y, Chen D, Zhao L, Zhang J. PMID: 42442332 [PubMed - as supplied by publisher]
	An advanced AI-driven deep learning framework for early detection and precise diagnosis of breast cancer from medical images. Comput Biol Med Karthiga R, Muthupandi M, Priskilla Manonmani S, Rajprabu R, Ashok R, Shravan Kumar B, Kalaimagal S, Samuthira Pandi V. PMID: 42442269 [PubMed - as supplied by publisher]
	Multi-omics analysis of arginine metabolism in ovarian cancer: A prognostic signature and GTF2F2-driven stromal remodeling. Transl Oncol Zhang D, Sheng J, Hu Y, Wang J, Sun Y, Zhou Y, Zhu X, Teng Y. PMID: 42442222 [PubMed - as supplied by publisher]
	Intratumoral collagen correlates with histological grade and patient prognosis in breast cancer. Exp Mol Pathol Sirinian C, Marchianò F, Kenanidou E, Zaverdas H, Samiotaki M, Ioannou AM, Theofilatos K, Argentou MI, Degn SE, Peroukidis S, Rusan M, Zolota V, Koutras A, Mavroudi S, Kourea H, Ng CKY, Papanastasiou AD. PMID: 42442131 [PubMed - as supplied by publisher]
	Uptake of breast cancer risk-management strategies among unaffected BRCA 1/2 carriers: a systematic review of international evidence. Eur J Surg Oncol Godino L, Innella G, Di Palo C, Bono GR, Turchetti D. PMID: 42442074 [PubMed - as supplied by publisher]
	Current Management of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in a Changing Landscape. J Clin Oncol Lipsyc-Sharf M, Hurvitz SA. PMID: 42441937 [PubMed - as supplied by publisher]
	Comparison of Moducare versus Wait-and-See approach for histologically proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) (MODUCIN1 TRIAL) - Study protocol. PLoS One Zouzoulas D, Sofianou I, Chatzistamatiou K, Theodoulidis V, Grimbizis G, Tsolakidis D. PMID: 42441577 [PubMed - indexed for MEDLINE]
	Machine Learning-Based Identification of Tamoxifen Resistance-Associated Genes and Their Application in Prognostic Modeling of Breast Cancer. J Vis Exp Gao C, Shi G, Hou L, Li L, Wang W, Li X, Liu SB. PMID: 42441516 [PubMed - indexed for MEDLINE]
	A narrative review of new strategies for immunotherapy combination treatment in platinum-resistant ovarian cancer: mechanisms, clinical evidence, and future directions. Front Oncol Zhang L, Ma X, Zhao X. PMID: 42441043 [PubMed]
	Immune heterogeneity and therapeutic resistance in gynecological malignancies. Front Immunol Zhang M, Guo B. PMID: 42440783 [PubMed - indexed for MEDLINE]
	Chemoimmunotherapy Combined With Antiangiogenic Therapy in Advanced Triple-Negative Breast Cancer: Real-World Outcomes From a Retrospective Cohort Study. MedComm (2020) Li Y, Lin J, Zhu M, Cai Z, Jin L, Li S, Shi Q, Lai H, Gong C, Liu Q. PMID: 42440745 [PubMed]
	Facilitators and barriers to cervical cancer screening among women living with HIV: a systematic review of qualitative studies. Front Public Health Zhou Y, Zheng X, Shao D, Cheng F. PMID: 42440658 [PubMed - indexed for MEDLINE]
	HPV viral load predicts immune exhaustion and prognosis in cervical neoplasia. Front Immunol Guo Y, Liu Y, He Y, Zhang Y, Li L, Lu W, Zhang Z. PMID: 42440646 [PubMed - indexed for MEDLINE]
	Neoadjuvant chemotherapy and immunotherapy followed by radical radiotherapy for locally advanced cervical cancer: efficacy and safety. Front Immunol Wei Q, Qu H, Yu Y, Gao S, Jia Y, Xia Y, Li X, Gu W. PMID: 42440555 [PubMed - indexed for MEDLINE]
	Deep transfer learning for breast cancer detection in underserved regions. Front Oncol Obaid M, Odeh SM, Ashqar HI, Abumwais A, Hodrob R. PMID: 42440459 [PubMed]
	AAPM/EFOMP TG282 versus dance dosimetry for digital breast tomosynthesis in the assessment pathway of a breast screening program. Med Phys Berrell JB, Delakis I. PMID: 42440380 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 332050

Seite 1 von 16603

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung